Rivastigmine for Alzheimer's Disease: Improvement Versus Reduced Worsening

Background: Alzheimer's disease (AD) is the most common cause of dementia in later life. It is manifested by gradual and progressive decline in cognitive function and ability to perform activities of daily living (ADL) and the development of behavioral disturbances. Progressive reduction in function...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Prim Care Companion J Clin Psychiatry
Principais autores:	Raskind, Murray, Kumar, Vinod, Malaty, Lisa, Messina, John, Hartman, Richard, Anand, Ravi
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Physicians Postgraduate Press, Inc. 2000
Assuntos:	Original Articles
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC181126/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15014648/ https://ncbi.nlm.nih.govhttps://doi.org/10.4088/pcc.v02n0406
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!